Maxolon
In brief
- Available in pharmacies across Australia, the UK and elsewhere; metoclopramide (Maxolon) is generally a prescription-only medicine, but in practice some pharmacies or online suppliers may supply it without a prescription/receipt depending on local regulations—check with your pharmacy and local laws.
- Maxolon is used for nausea and vomiting (including post‑operative and chemotherapy), gastroparesis, gastro‑oesophageal reflux and as an adjunct in acute migraine; it is a dopamine D2 receptor antagonist and prokinetic that blocks the chemoreceptor trigger zone and increases gastrointestinal motility.
- Usual dose for adults is 10 mg up to three times daily (maximum 30 mg/day); in children typical dosing is 0.1–0.15 mg/kg per dose with a maximum of 0.5 mg/kg/day; dose reductions are recommended in the elderly and in renal impairment.
- Administered orally as 10 mg tablets (also available as orally disintegrating tablets and 5 mg/5 mL oral solution) or parenterally as 5 mg/mL injection for IM/IV use.
- Onset of effect: oral tablets usually begin to work within about 30–60 minutes; orally disintegrating formulations may act faster; IV administration works within minutes and IM within around 10–15 minutes.
- Duration of action is typically about 4–6 hours (plasma half‑life approximately 5–6 hours), although effects may be prolonged in the elderly or with renal impairment.
- Alcohol warning: avoid alcohol while taking Maxolon—alcohol increases drowsiness and CNS depression and may worsen side effects, especially when combined with other sedatives.
- The most common side effec is drowsiness (other common effects include diarrhoea, restlessness, headache and potential extrapyramidal symptoms with acute or prolonged use).
- Would you like to try maxolon without a prescription?
Latest Research Findings — Austrian And EU Data (2022–2024)
Basic Maxolon Information
- INN (International Nonproprietary Name): Metoclopramide.
- Brand Names Available In Australia: Maxolon; Gastropraide; generics labelled as metoclopramide.
- ATC Code: A03FA01.
- Forms & Dosages: Tablets 10 mg (blister packs 10/20/30); oral solution 5 mg/5 mL in 100 mL bottles; injection 5 mg/mL ampoules/vials (2 mL, 10 mL).
- Manufacturers In Australia: Aspen Pharmacare; Alphapharm; local generics marketed alongside international suppliers such as Teva.
- Registration Status In Australia: Registered and marketed; prescription-only (Rx) in Australia.
- OTC / Rx Classification: Prescription Only (Rx) due to neurological risk profile.
What has recent regulatory review shown about metoclopramide?
European Medicines Agency safety reviews and PRAC communications to 2024 reconfirm metoclopramide’s benefit for short‑term control of acute nausea and vomiting while emphasising safety signals with prolonged or high‑dose use.
Austrian pharmacovigilance summaries from AGES mirror the EU findings and report disproportionate adverse event reports in elderly patients and in paediatric off‑label use.
Systematic reviews published between 2022 and 2024 show metoclopramide is more effective than placebo for postoperative nausea and for some chemotherapy‑induced nausea, though 5‑HT3 antagonists are often preferred in oncology settings.
Regulatory guidance stresses limiting treatment to the shortest effective period to reduce the risk of extrapyramidal symptoms and tardive dyskinesia.
Key product details used in these assessments are INN Metoclopramide, ATC A03FA01, and common brands such as Maxolon and Reglan, supplied as 10 mg tablets, 5 mg/5 mL syrup and 5 mg/mL injection.
| Efficacy Endpoint | Result (2022–2024 Reviews) | Safety Signal |
|---|---|---|
| Postoperative Nausea | Superior to placebo for symptom reduction | Low short‑term EPS risk; increased with repeat doses |
| Chemotherapy‑Induced Nausea | Effective in some regimens; less used than ondansetron | Higher EPS with repeated use during cycles |
| Chronic Use (Gastroparesis) | Symptom improvement reported under specialist care | Tardive dyskinesia risk with long‑term use |
Clinical Effectiveness In Austria — Outcomes And Real‑World Data
How is metoclopramide used in everyday Austrian practice and what outcomes do we see?
Social insurance prescription records and hospital discharge data show metoclopramide is still prescribed for acute nausea, postoperative emesis and as an adjunct in acute migraine treatment.
Overall utilisation declined after EMA safety communications, with clinicians choosing shorter courses and alternative agents where appropriate.
Observational analyses from Austrian emergency departments report higher rates of acute dystonic reactions in younger patients and more neurological adverse events in those on long‑term therapy.
In ambulatory care, short courses from a single dose up to five days give reliable nausea score reduction and fewer vomiting episodes, when used appropriately.
Community pharmacists follow Apothekerkammer guidance by counselling patients on movement‑disorder signs and recording treatments in the national E‑Medikation system.
- Nausea score reduction (validated scales) over 24–48 hours.
- Number of vomiting episodes avoided within 24 hours.
- Emergency department visits for extrapyramidal symptoms.
- Rate of hyperprolactinaemia with prolonged courses.
| Metric | Austria (Real‑World) | EU Summary |
|---|---|---|
| Prescriptions (post‑2020) | Declining; shorter courses preferred | Overall stable but with stricter duration guidance |
| ED Presentations For Acute Dystonia | Higher in younger patients | Reported across EU pharmacovigilance systems |
Indications And Extended Uses — Approved Versus Off‑Label
What is metoclopramide licensed for, and when is off‑label use seen?
Approved indications in EMA and national summaries include short‑term treatment of nausea and vomiting, postoperative nausea, some chemotherapy‑related nausea and use as an adjunct in acute migraine.
Specialist‑supervised symptomatic treatment of gastroparesis is an approved route but requires careful monitoring due to tardive dyskinesia risk.
Common off‑label practices in Austrian hospitals include management of refractory paediatric nausea and use during diagnostic prokinetic testing, although vigilance is advised.
- Approved Uses
- Short‑term control of acute nausea and vomiting, postoperative emesis, adjunctive migraine therapy, specialist‑managed gastroparesis.
- Common Off‑Label Uses
- Refractory paediatric nausea, diagnostic prokinetic testing under supervision.
Standard adult dosing is 10 mg up to three times daily (maximum 30 mg/day), and paediatric dosing is restricted to 0.1–0.15 mg/kg per dose with a maximum of 0.5 mg/kg/day when no safer alternative exists.
- Checklist For Prescribers: Document indication and expected duration on the prescription.
- Checklist For Prescribers: Use the lowest effective dose and limit treatment to a single dose up to five days for most acute indications.
- Checklist For Prescribers: Arrange specialist review if therapy is needed longer than 4–12 weeks for gastroparesis.
Composition And Market Brands — Austrian Market View
Which brands and formulations of metoclopramide are commonly available in Austria?
Metoclopramide is supplied under INN labelling and as brand products such as Maxolon and generics from manufacturers like Aspen, Accord and Teva.
Available forms include 10 mg tablets, a 5 mg/5 mL oral solution and injectable ampoules or vials at 5 mg/mL for IM/IV use in hospitals or emergency kits.
Packaging in Austria typically shows manufacturer branding, batch numbers, expiry dates and German‑language patient leaflets in accordance with local law.
| Brand | Form | Typical Pack Sizes | Local Notes |
|---|---|---|---|
| Maxolon | Tablets 10 mg | Blister packs 10 / 20 / 30 | Common retail brand; leaflets in German |
| Generics (Aspen, Teva) | Tablets, solution, injection | Blister packs; 100 mL syrup; ampoules 2 mL / 10 mL | Widely used; often lower cost |
| Gastropraide | Tablets, solution | Varies by pack | Marketed in Australia |
Pharmacy teams commonly explain excipient differences for patients with allergies and check storage and expiry before dispensing.
Contraindications And Special Precautions
Who should not take metoclopramide, and who needs extra caution?
Absolute contraindications include known hypersensitivity, gastrointestinal obstruction or perforation, pheochromocytoma, epilepsy or history of seizures, Parkinson’s disease, and prolactin‑dependent tumours.
Austrian pharmacovigilance highlights elderly patients, those with renal impairment and patients taking antipsychotics as higher risk groups for extrapyramidal reactions.
Pharmacists in rural Austria often counsel patients who work in agriculture or with machinery that metoclopramide can cause drowsiness and acute movement disorders that impair safe operation.
- Checklist — Contraindications: Hypersensitivity; GI obstruction/bleeding; pheochromocytoma; epilepsy; Parkinson’s disease; prolactin‑dependent tumours.
- Precautionary Steps: Review renal and hepatic function and current medication list; document counselling for women of childbearing age and breastfeeding mothers.
Decision Flow For Pharmacists And Prescribers: If contraindication present, do not dispense; if relative risk factors present, use reduced dose and monitor closely; if extrapyramidal signs occur, stop drug and seek urgent medical review.
Dosage Guidance — National Practice And Adjustments
How should dosing be tailored in everyday practice?
Standard adult dosing is 10 mg up to three times daily, with a maximum of 30 mg per day.
Children are dosed at 0.1–0.15 mg/kg per dose with a maximum of 0.5 mg/kg/day and are only treated when no safer alternative exists.
Austrian and EU practice emphasises the lowest effective dose for the shortest time, typically a single dose up to five days for acute nausea, and specialist oversight for courses beyond four to 12 weeks for gastroparesis.
| Patient Group | Standard Dose | Adjustment |
|---|---|---|
| Adult | 10 mg up to 3× daily (max 30 mg/day) | Use lowest effective dose; avoid long‑term use |
| Paediatric (1–18 yrs) | 0.1–0.15 mg/kg/dose | Max 0.5 mg/kg/day; only if alternatives fail |
| Renal Impairment (GFR <30 mL/min) | Reduce dose | Half dose or double dosing interval |
| Hepatic Impairment | Use with caution | Monitor CNS effects; consider dose reduction |
Counselling Points For Missed Doses: Take as soon as remembered unless nearly time for next dose and never double up.
Emergency Signs Of Overdose: Confusion, severe drowsiness, abnormal movements or seizures require urgent hospital assessment.
Drug Interactions — Important Interactions In E‑Medication Records
Which medicines should you check before dispensing metoclopramide?
Major interaction concerns include additive extrapyramidal risk with antipsychotics and other dopamine antagonists and increased CNS depression with sedatives and alcohol.
Serotonergic agents can contribute to neurotoxicity in combination, and drugs altering renal clearance may change metoclopramide exposure.
In Austrian E‑Medikation systems pharmacists frequently see automatic flags when antipsychotics and metoclopramide appear together.
- Major Interacting Classes: Antipsychotics/dopamine antagonists; CNS depressants including benzodiazepines and alcohol; serotonergic drugs; medications impacting renal elimination.
- Pharmacy Action: Check E‑Medikation, counsel patient on avoiding alcohol, and contact prescriber if risky combinations are present.
| Interacting Drug Class | Risk | Severity For Dispensing |
|---|---|---|
| Antipsychotics | Increased extrapyramidal effects | High — review and consider alternatives |
| CNS Depressants (incl. alcohol) | Enhanced sedation | Moderate — counsel on activity limits |
| Serotonergic Agents | Rare risk of neurotoxicity | Moderate — monitor closely |
Cultural Characteristics And Patient Behaviour In Austria
How do Austrian patients approach nausea treatment and pharmacy care?
Surveys and pharmacy helpline data show many Austrians seek rapid relief for nausea and often consult pharmacists before seeing a GP.
Rural patients report limited after‑hours access to Apotheken and a tendency to cross‑border shop in Germany, Czechia or Hungary for pricing or brand preference when able.
Urban customers are more likely to use chain pharmacies with integrated e‑card and E‑Medikation systems that enable electronic follow‑up and automatic alerts.
| Setting | Typical Behaviour | Access Pattern |
|---|---|---|
| Urban (Vienna, Graz) | Prefer quick pharmacist advice; use e‑card | Good stock levels; shorter delivery times |
| Rural | Closer doctor–pharmacy ties; after‑hours limitations | Occasional cross‑border shopping; stock variability |
Pharmacists trained under Apothekerkammer standards give clear verbal instructions and document counselling in the patient file or E‑Medikation record.
Availability And Price Overview In Australia
Where and how can patients obtain metoclopramide and how is it reimbursed?
In Austria metoclopramide is prescription‑only and reimbursement by Sozialversicherung depends on correct indication coding on the Rezept.
Typical retail pack sizes include tablets as blisters of 10, 20 or 30, syrup in 100 mL bottles and injection ampoules kept by hospital and some rural pharmacies.
Generics from Aspen, Teva and Accord are commonly stocked and regional reimbursement rules cause some variation in patient co‑payments.
| Form | Indicative Retail Price Range (EUR) | Reimbursement Notes |
|---|---|---|
| Tablets 10 mg (blister) | Low to moderate depending on generic vs brand | Reimbursed for approved indications when coded correctly |
| Syrup 5 mg/5 mL (100 mL) | Moderate | Stocked by community pharmacies; check reimbursement |
| Injection 5 mg/mL ampoules | Moderate to higher (hospital supply) | Usually hospital stock; outpatient access limited |
Note About Online Ordering: In our online pharmacy, maxolon is available without a prescription, with discreet delivery to Australia in 5-14 days.
Comparable Medicines And Treatment Preferences
What are realistic alternatives to metoclopramide and when are they chosen?
Alternatives commonly used in Austria include domperidone, ondansetron and granisetron, plus non‑pharmacological measures for mild nausea.
Ondansetron and granisetron (5‑HT3 antagonists) are preferred in many oncology settings, while domperidone offers prokinetic effects with lower central penetration but carries cardiac QT concerns.
Choice depends on indication, patient comorbidities such as Parkinson’s disease and Sozialversicherung coverage for the specific diagnosis.
| Agent | Strengths | Key Risks | Typical Austrian Use Case |
|---|---|---|---|
| Metoclopramide | Rapid onset; multiple formulations including injection | EPS, tardive dyskinesia with long use | Acute postoperative nausea, acute migraine adjunct |
| Domperidone | Lower CNS penetration | Cardiac QT prolongation | Non‑CNS nausea where cardiac risk acceptable |
| Ondansetron / Granisetron | Effective in chemo/radiotherapy nausea | Constipation; rare cardiac effects | Oncology settings |
Frequently Asked Questions — Austrian Pharmacy FAQs
Is Maxolon safe in pregnancy?
Use in pregnancy is allowed only if the expected benefit justifies the potential risk to the foetus, and this decision should be documented on the prescription.
How long can I take metoclopramide?
Treatment is usually limited to a single dose up to five days for acute nausea; longer courses up to 4–12 weeks require specialist oversight and clear monitoring for movement disorders.
Will metoclopramide affect my driving or work?
Yes, it can cause drowsiness or acute dystonia; avoid driving or operating machinery until you know how the medicine affects you.
Can children take it?
Paediatric use is restricted; dosing is weight‑based and usually only when alternatives are unsuitable and under specialist or prescriber guidance.
- Pharmacist Counselling Tips: Record indication in E‑Medikation, advise on duration limits and watch for early signs of movement disorders.
Guidelines For Proper Use — Pharmacy Counselling Checklist
What steps should a pharmacist follow at dispensing and counselling?
Confirm the indication and ensure the duration is stated on the prescription or agree an appropriate short course with the prescriber.
Review the patient’s concomitant medicines via E‑Medikation for antipsychotics, serotonergic drugs or CNS depressants that increase risk.
Counsel the patient on the correct dose, explain common side effects and describe urgent signs such as sustained involuntary movements or severe drowsiness.
Advise the patient to avoid alcohol while taking metoclopramide and to seek medical review if symptoms persist beyond the planned course.
- Confirm indication and duration on the Rezept and record in patient file.
- Check E‑Medikation for interactions and high‑risk combinations.
- Explain dosing schedule, missed‑dose instructions and storage (tablets <25°C; injections per manufacturer).
- Describe adverse signs (acute dystonia, tremor, abnormal involuntary movements) and action: stop drug and seek urgent care.
- Arrange follow‑up for any therapy beyond five days and inform the prescriber of cumulative exposure.
Printable Quick Reference For Adverse Signs:
Acute Dystonia: sudden neck or eye spasms — stop drug and seek emergency care.
Tardive Dyskinesia: repetitive involuntary movements after weeks/months — refer to specialist and stop where possible.
Delivery Across Australia
| City | Region | Delivery time |
|---|---|---|
| Sydney | New South Wales | 5-7 days |
| Melbourne | Victoria | 5-7 days |
| Brisbane | Queensland | 5-7 days |
| Perth | Western Australia | 5-7 days |
| Adelaide | South Australia | 5-7 days |
| Canberra | Australian Capital Territory | 5-7 days |
| Hobart | Tasmania | 5-9 days |
| Darwin | Northern Territory | 5-9 days |
| Gold Coast | Queensland | 5-7 days |
| Newcastle | New South Wales | 5-9 days |
| Wollongong | New South Wales | 5-9 days |
| Geelong | Victoria | 5-9 days |
| Cairns | Queensland | 5-9 days |
